DK3019525T3 - Antistoffer til beta2-glycoprotein i og terapeutiske anvendelser deraf - Google Patents
Antistoffer til beta2-glycoprotein i og terapeutiske anvendelser deraf Download PDFInfo
- Publication number
- DK3019525T3 DK3019525T3 DK14741228.2T DK14741228T DK3019525T3 DK 3019525 T3 DK3019525 T3 DK 3019525T3 DK 14741228 T DK14741228 T DK 14741228T DK 3019525 T3 DK3019525 T3 DK 3019525T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibodies
- therapeutic uses
- beta2 glycoprotein
- beta2
- glycoprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361844505P | 2013-07-10 | 2013-07-10 | |
| PCT/EP2014/064400 WO2015004038A1 (en) | 2013-07-10 | 2014-07-07 | ANTIBODIES TO β2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3019525T3 true DK3019525T3 (da) | 2019-07-01 |
Family
ID=51211192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14741228.2T DK3019525T3 (da) | 2013-07-10 | 2014-07-07 | Antistoffer til beta2-glycoprotein i og terapeutiske anvendelser deraf |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9777057B2 (da) |
| EP (1) | EP3019525B1 (da) |
| JP (1) | JP6440036B2 (da) |
| CA (1) | CA2917661C (da) |
| DK (1) | DK3019525T3 (da) |
| ES (1) | ES2729317T3 (da) |
| WO (1) | WO2015004038A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10098960B2 (en) | 2015-04-03 | 2018-10-16 | Ucl Business Plc | Polymer conjugate |
| CN114716547B (zh) * | 2022-05-18 | 2023-11-21 | 珠海丽禾医疗诊断产品有限公司 | 一种包括抗原结合结构域的结合蛋白及其生产方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9809839D0 (en) * | 1998-05-09 | 1998-07-08 | Glaxo Group Ltd | Antibody |
| IL125262A0 (en) | 1998-07-07 | 1999-03-12 | Yeda Res & Dev | Synthetic peptides and pharmaceutical compositions comprising them |
| CN102816238A (zh) | 2011-07-28 | 2012-12-12 | 江苏大学 | IgG1型抗人β2糖蛋白I单克隆抗体及其制备和应用 |
-
2014
- 2014-07-07 JP JP2016524765A patent/JP6440036B2/ja active Active
- 2014-07-07 DK DK14741228.2T patent/DK3019525T3/da active
- 2014-07-07 WO PCT/EP2014/064400 patent/WO2015004038A1/en active Application Filing
- 2014-07-07 CA CA2917661A patent/CA2917661C/en active Active
- 2014-07-07 EP EP14741228.2A patent/EP3019525B1/en active Active
- 2014-07-07 ES ES14741228T patent/ES2729317T3/es active Active
- 2014-07-07 US US14/903,284 patent/US9777057B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2917661C (en) | 2023-09-12 |
| US9777057B2 (en) | 2017-10-03 |
| JP2016531092A (ja) | 2016-10-06 |
| EP3019525B1 (en) | 2019-04-17 |
| WO2015004038A1 (en) | 2015-01-15 |
| CA2917661A1 (en) | 2015-01-15 |
| US20160152696A1 (en) | 2016-06-02 |
| EP3019525A1 (en) | 2016-05-18 |
| JP6440036B2 (ja) | 2018-12-19 |
| ES2729317T3 (es) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3121164T3 (da) | Sulfamoylpyrrolamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| CL2015001924A1 (es) | Anticuerpos anti-pdgfr-beta y usos relacionados. | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| DK3019200T3 (da) | Oligonukleotid-ligand-konjugater og fremgangsmåde til fremstiling deraf | |
| DK2963056T3 (da) | Insulinanalog og anvendelse deraf | |
| DK3089994T3 (da) | Fabs-in-tandem-immunglobulin og anvendelser deraf | |
| DK2844672T3 (da) | Humane antistoffer over for Fel d1 og fremgangsmåder til anvendelse deraf | |
| DK2914291T3 (da) | Anti-komplement-c1s-antistoffer og anvendelser deraf | |
| DK3019533T3 (da) | Dobbeltspiraliserede immunoglobulinfusionproteiner og sammensætninger deraf | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
| DK3381943T3 (da) | Anti-kit-antistoffer og anvendelser deraf | |
| BR302013004392S1 (pt) | Configuração aplicada emmetal sanitário | |
| DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
| BR302013004540S1 (pt) | Configuração aplicada em jóias | |
| BR302013004506S1 (pt) | Configuração aplicada em jóias | |
| DK3311845T3 (da) | Terapeutiske polymernanopartikler og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3086807T3 (da) | Antistoffer og fremgangsmåder til anvendelse | |
| CL2015002750A1 (es) | Anticuerpos humanos pac1 | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK4032985T3 (da) | Mikropeptider og anvendelse deraf til at modulere genekspressionen | |
| DK3065771T3 (da) | Fremgangsmåder og sammensætninger til vedvarende immunterapi | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf |